Wall Street Experts
ver. ZuMIgo(08/25)
ImmunoPrecise Antibodies Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 24
EBIT TTM (mln): -15
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
5 |
11 |
14 |
18 |
19 |
21 |
25 |
Przychód Δ r/r |
0.0% |
-85.6% |
-95.6% |
17.0% |
-100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
38.7% |
106.9% |
100.8% |
28.7% |
27.4% |
8.1% |
6.7% |
18.6% |
Marża brutto |
100.0% |
100.0% |
100.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
84.3% |
100.0% |
45.0% |
48.5% |
57.1% |
64.4% |
56.7% |
56.0% |
49.2% |
EBIT (mln) |
-1 |
-1 |
-0 |
-0 |
-0 |
-1 |
-0 |
-0 |
-0 |
-1 |
-0 |
-0 |
-0 |
-0 |
-0 |
-0 |
-0 |
0 |
-1 |
-5 |
-6 |
-4 |
-7 |
-16 |
-26 |
-14 |
EBIT Δ r/r |
0.0% |
-1.6% |
-87.9% |
56.7% |
-32.2% |
307.1% |
-68.7% |
98.6% |
4.2% |
193.7% |
-67.1% |
-26.8% |
-10.1% |
-21.5% |
-60.9% |
20.0% |
-61.9% |
-752.0% |
-671.4% |
255.5% |
26.3% |
-34.3% |
62.5% |
137.2% |
65.3% |
-47.3% |
EBIT (%) |
-2370.3% |
-16219.3% |
-45024.5% |
-60320.7% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
12.8% |
-52.7% |
-90.6% |
-57.0% |
-29.1% |
-37.1% |
-81.5% |
-126.3% |
-56.1% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
EBITDA (mln) |
1 |
1 |
-0 |
-0 |
-0 |
0 |
-0 |
-0 |
-0 |
-0 |
-0 |
-1 |
-0 |
-0 |
-0 |
-0 |
-0 |
0 |
-5 |
-4 |
-4 |
-0 |
-0 |
-12 |
-21 |
-23 |
EBITDA(%) |
1694.4% |
11601.0% |
-44767.9% |
-39493.8% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
14.6% |
-196.1% |
-81.5% |
-36.0% |
-2.6% |
-1.0% |
-62.6% |
-102.9% |
-93.6% |
Podatek (mln) |
1 |
1 |
0 |
0 |
0 |
0 |
-0 |
-1 |
0 |
-0 |
0 |
-0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
0 |
-0 |
1 |
1 |
-1 |
-2 |
Zysk Netto (mln) |
-1 |
-1 |
-0 |
-0 |
-0 |
-1 |
-0 |
0 |
-0 |
-1 |
-0 |
-1 |
-5 |
-0 |
-0 |
0 |
-0 |
0 |
-5 |
-5 |
-8 |
-5 |
-7 |
-17 |
-27 |
-27 |
Zysk netto Δ r/r |
0.0% |
-0.4% |
-89.2% |
75.3% |
20.6% |
99.0% |
-66.9% |
-189.0% |
-343.3% |
86.8% |
-37.5% |
109.6% |
431.6% |
-94.8% |
-65.3% |
-172.5% |
-189.7% |
-342.4% |
-3664.6% |
-4.0% |
47.3% |
-35.1% |
48.4% |
127.6% |
59.0% |
2.3% |
Zysk netto (%) |
-2371.7% |
-16414.5% |
-40696.1% |
-60986.3% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
8.0% |
-204.7% |
-95.0% |
-69.7% |
-35.2% |
-41.0% |
-86.3% |
-128.5% |
-110.8% |
EPS |
-8.21 |
-8.17 |
-0.88 |
-1.32 |
-1.29 |
-2.4 |
-0.6 |
0.45 |
-1.07 |
-1.81 |
-1.0 |
-1.8 |
-9.58 |
-0.5 |
-0.18 |
0.11 |
-0.11 |
0.1 |
-1.36 |
-0.57 |
-0.61 |
-0.36 |
-0.45 |
-0.85 |
-1.07 |
-1.06 |
EPS (rozwodnione) |
-8.21 |
-8.17 |
-0.88 |
-1.32 |
-1.29 |
-2.17 |
-0.6 |
0.45 |
-1.07 |
-1.81 |
-1.0 |
-1.8 |
-9.58 |
-0.5 |
-0.18 |
0.11 |
-0.11 |
0.1 |
-1.36 |
-0.57 |
-0.61 |
-0.36 |
-0.45 |
-0.85 |
-1.07 |
-1.06 |
Ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
4 |
9 |
13 |
14 |
16 |
20 |
25 |
26 |
Ważona ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
4 |
9 |
13 |
14 |
16 |
20 |
25 |
26 |
Waluta |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |
CAD |